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Coxsackie B2 Virus 
Infection
Causing Multiorgan Failure and  
Cardiogenic Shock in a 42-Year-Old Man
Infections from coxsackie B2 viruses often cause viral myocarditis and, only rarely, multi-
system organ impairment. We present the unusual case of a 42-year-old man in whom 
coxsackie B2 virus infection caused multiorgan infection, necessitating distal pancre-
atectomy, splenectomy, renal dialysis, and venoarterial extracorporeal membrane oxy-
genation with mechanical ventilation. In addition, the patient had a rapid-eye-movement 
sleep–related conduction abnormality that caused frequent sinus pauses of longer than 
10 s, presumably due to myocarditis from the coxsackievirus infection. He recovered after 
permanent pacemaker placement and was discharged from the hospital. We discuss our 
aggressive supportive care and the few other reports of multiorgan impairment from cox-
sackieviruses. (Tex Heart Inst J 2019;46(1):32-5)
C oxsackie B virus (CVB) infections usually involve a single organ, such as the pancreas or heart; rarely, they affect 2 organs. We present the case of a patient in whom coxsackie B2 virus (CVB2) infection caused widespread multiorgan 
impairment, including cardiogenic shock complicated by a conduction disorder, and 
we discuss our treatment decisions.
Case Report
In summer 2016, a 42-year-old man with a history of obstructive sleep apnea pre-
sented with a 7-day history of vague abdominal pain followed by a 3-day history of 
worsening high-grade fever, malaise, and sharp abdominal pain. His blood pressure 
and laboratory values were normal, except for lactate dehydrogenase (mildly elevated 
at 272 U/L) and a platelet count of 110 ×109/L. An abdominal computed tomogram 
revealed pancreatic heterogeneity, peripancreatic lymphadenopathy, and splenic in-
farction (Fig. 1). Our initial diagnosis was focal severe pancreatitis, complicated by 
worsening acute renal insufficiency, which indicated the possibility of glomerulone-
phritis. Results of urinalysis and renal ultrasound were nondiagnostic. Initial therapy 
included intravenous f luids and avoidance of nephrotoxic agents. Approximately one 
week after hospital admission, the patient underwent distal pancreatectomy and sple-
nectomy for diagnostic and therapeutic purposes; substantial intra-abdominal inf lam-
mation precluded a renal biopsy.
 Postoperatively, the patient’s fever persisted. Acute dyspnea developed, accompanied 
by electrocardiographic changes consistent with inferolateral myocardial injury or 
myopericarditis (Fig. 2). Furthermore, the patient had an elevated serum troponin 
level of >73 ng/mL associated with a peak creatine kinase-MB level of 540 ng/mL. 
Coronary catheterization revealed no substantial coronary artery disease but did show 
markedly elevated filling pressures with reduced cardiac output, which necessitated 
the placement of an intra-aortic balloon pump. Diuresis and milrinone therapy were 
also begun. Transthoracic echocardiograms suggested a left ventricular ejection frac-
tion (LVEF) of 0.15, and the diagnosis was acute fulminant myocarditis resulting in 
acute systolic heart failure.
 The patient’s worsening cardiac status was complicated by pulmonary edema and 
oliguric renal failure. After 2 days, his therapy was escalated to venoarterial extracor-
poreal membrane oxygenation (VA-ECMO), mechanical ventilation, and continuous 
renal replacement therapy. Within 5 days, his cardiopulmonary hemodynamic status 
improved enough to enable both decannulation from VA-ECMO and extubation, and 
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dialysis was discontinued soon thereafter when his renal 
function recovered. An echocardiogram after decannu-
lation confirmed a mildly depressed LVEF of 0.50.
 Pancreatic biopsy specimens revealed lymphoid pro-
liferation, inf lammation, and focal necrotic f ibrosis; 
results of a splenic biopsy confirmed infarction and in-
f lammation; and peripancreatic lymph node specimens 
were reactive. Cardiac biopsy results included inf lam-
mation but no infarction or necrosis; the diagnostic 
value was limited because the sample had been obtained 
from atrial tissue during VA-ECMO cannulation. An 
extensive multidisciplinary diagnostic evaluation of im-
munologic and infectious factors was performed (Table 
I). Previous exposure to Mycoplasma pneumoniae was 
detected. Of note, the CVB2 antibody titer was initially 
positive at 1:80 (normal, <1:10); 21 days later, it substan-
tially increased to >1:640.
 The patient’s hospital course was further complicated 
by frequent, prolonged (>10 s) episodes of sinus arrest 
during later stages of sleep. These were not associated 
with obstructive sleep apnea (the patient was using his 
continuous positive airway pressure unit, at usual set-
tings) or with hypoxia, as confirmed by nocturnal con-
tinuous oximetry readings. The pauses also occurred in 
the stepdown unit, where the patient got normal hours 
of sleep. Cardiac electrophysiologists recommended per-
manent pacemaker implantation, which was done, and 
the patient was discharged from the hospital in stable 
condition after a total stay of 42 days (Fig. 3). Follow-
up interrogations of the pacemaker revealed no pacing 
requirements. The patient ultimately underwent ortho-
topic heart transplantation and, as of November 2018, 
was doing well.
Fig. 1  Abdominal computed tomogram upon admission shows 
focal pancreatic inflammation (arrow) and concomitant splenic 
infarction (arrowhead).
Fig. 2  Electrocardiogram upon onset of dyspnea shows PR-
segment depression and ST-segment elevation in leads II, III and 
aVF, consistent with myocardial ischemia.
TABLE I. Results of Tests for Immunologic and Infectious 
Factors
         Test
Initial 
Result
Repeat 
Result
Reference 
Range
Chlamydia pneumoniae
   IgG 1:128 — <1:64
   IgM <1:10 — <1:10
C. trachomatis
   IgG <1:64 — <1:64
   IgM <1:10 — <1:10
C. psittaci
   IgG <1:64 — <1:64
   IgM <1:10 — <1:10
Coxsackievirus antibody type
   A2 <1:8 — <1:8
   A4 <1:8 — <1:8
   A7 <1:8 — <1:8
   A9 <1:8 — <1:8
   A10 <1:8 — <1:8
   A16 <1:8 — <1:8
   B1 1:40 1:80 <1:10
   B2 1:80 >1:640 <1:10
   B3 <1:10 <1:10 <1:10
   B4 1:80 1:40 <1:10
   B5 1:20 1:20 <1:10
   B6 <1:10 <1:10 <1:10
Ehrlichia chaffeensis
   IgG <1:64 — <1:64
   IgM <1:20 — <1:20
Leptospira antibody 
   IgM
 
Negative
 
—
 
Negative
Mumps antibody 
   IgM
 
Negative
 
—
 
Negative
Lyme disease 
serology
Negative — Negative
Mycoplasma pneumoniae (U/mL)
   IgG 473 — <100
   IgM 24 — <100
Histoplasma 
antibody (urine)
Not detected — Not detected
IgG = immunoglobulin G; IgM = immunoglobulin M
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Discussion
Coxsackievirus B, a well-known cause of myocarditis, 
also causes pancreatitis, hepatitis, skin rashes, aseptic 
meningitis,1-5 and acute renal failure.6-10 The link be-
tween coxsackieviruses and kidney injury is less well 
established; however, coxsackieviruses have also led to 
acute glomerulonephritis8,9 and infection of mesangial 
cells.10 Although multiorgan involvement of CVB is 
very rare, infants have died of multiorgan failure,11,12 a 
previously healthy adult patient had cardiac tampon-
ade caused by myopericarditis and died of multiorgan 
failure,13 and a renal transplant patient had pancreatitis 
and myocarditis.14 Two cases of cardiac, pancreatic, and 
hepatic (triple) involvement have been reported—one 
caused by CVB215 and the other by coxsackievirus A4.4 
Another patient had myopericarditis, pleuritis, and 
acute liver failure caused by CVB, with elevated titers 
of serotypes CVB1, -2, and -6.16 Our patient’s case is 
unusual not only because of the organ systems involved, 
but also the complex sequence of organ involvement, 
from pancreas and spleen to kidneys and heart. Al-
though some of the earlier patients also had substantial 
disease processes (particularly in compromised hosts, 
unlike our patient), aggressive intervention ultimately 
enabled their recovery. Finally, our patient’s illness re-
sulted in a conduction system abnormality associated 
with rapid-eye-movement (REM) sleep that was due 
presumably to severe acute myocarditis.
 Our patient’s positive CVB2 titer (initially 1:80) was 
4 times normal. Its increase to >1:640 indicated acute 
infection. The weakly positive titers of serotypes CVB1, 
-2, -4, and -5 indicated cross-reactivity, which is also 
consistent with acute CVB infection.
 A similar sequential progression of symptoms has 
been reported.15 Coxsackieviruses are known to have a 
multiphasic course: Zaoutis and Klein2 called the initial 
organ-seeding infection “minor viremia” and replication 
within those organs “major viremia.” In addition, ex-
periments involving mice inoculated with CVB strains 
produced pancreatitis, followed by myocarditis.11 Given 
the lack of other reasonable causes in our patient (non-
diagnostic urinalysis and renal ultrasound, no hypo-
tension, and nothing apparent on the initial computed 
tomogram with contrast medium), we think that his 
initial renal insufficiency was also due to CVB2.6-10 The 
renal insult was certainly exacerbated by the cardiogenic 
shock later in his hospital course.
 Currently, the treatment of coxsackievirus infection 
mainly constitutes supportive measures, and indeed 
our patient recovered rapidly after aggressive support-
ive care. Of importance, the use of VA-ECMO that 
ultimately enabled his recovery is well established as 
temporary support for shock in the presence of acute 
fulminant myocarditis; it enables substantial recovery 
of LVEF and favorable long-term outcomes.17,18
 Last, our patient’s frequent episodes of sinus arrest last-
ed >10 s but occurred only while he slept. They persisted 
despite optimal continuous positive airway pressure 
therapy and were not associated with hypoxia. Because 
the pauses occurred unprovoked, only during sleep, and 
always in the early morning, we think that they were 
associated with REM sleep. As in other patients with 
REM-related bradyarrhythmias, daytime telemetry read-
ings and electrocardiograms showed nothing unusual.19 
The prevalence of REM-related bradyarrhythmia is un-
known; however, the condition is thought to be rare, 
and it is typically detected during unrelated monitor-
ing.19,20 The most likely cause of REM-related sinus arrest 
is vagal overactivity and hyperactivation of baroreceptors 
that create abnormal autonomic regulation of the car-
diovascular system. Among the few case descriptions, 
REM-related sinus arrest seems to be prevalent in young 
and middle-aged men.15
 Cardiac conduction system abnormalities, includ-
ing sinoatrial and atrioventricular conduction block of 
varying severity, are a known complication of some 
forms of myocarditis, typically Lyme carditis, cardiac 
sarcoidosis, and idiopathic giant-cell myocarditis.21-23 
Although our patient’s cardiac tissue specimen was not 
specifically tested for CVB, the conduction abnormal-
ity was probably caused by myocardial injury. To our 
knowledge, a REM-related conduction abnormality 
secondary to CVB myocarditis has not been described. 
We consider it unlikely that our patient’s sinus arrests 
were an incidental finding, because previous sleep stud-
ies for his obstructive sleep apnea had not revealed 
them. They were possibly related to an indolent sino-
atrial conduction abnormality caused by recent acute 
myocarditis and were unmasked during REM sleep, 
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Fig. 3  Graph shows the patient’s hospital course. Bars indicate 
the time of onset and duration of the symptom or intervention. 
 
AKI = acute kidney injury; CRRT = continuous renal replacement 
therapy; HD = hemodialysis; IABP = intra-aortic balloon pump; 
VA-ECMO = venoarterial extracorporeal membrane oxygenation
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especially given that they occurred when the patient had 
finally achieved optimal, normal sleep patterns and had 
improved overall as the myocarditis resolved. This con-
clusion is supported by the results of pacemaker inter-
rogations, which revealed no pacing requirements after 
his discharge from the hospital.
 This is an unusual case of CVB2 infection, perhaps 
a f irst, in an adult patient who presented with the re-
ported sequence of multisystem organ involvement, 
responded to organ-supportive therapy, and needed 
permanent pacemaker therapy.
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